Alpine Partners USVI’s Amgen AMGN Stock Holding History

Alpine Partners USVI’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-16,772	Closed	-$1.65M	–	40
2013 Q2	$1.65M	Buy	+16,772	New	+$1.74M	0.54%	32

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Alpine Partners USVI's AMGN Position: Q3 2013 in Review

Alpine Partners USVI sold out of Amgen (AMGN) in Q3 2013, closing a stake of 16,772 shares — an estimated $1.65M sold.

Alpine Partners USVI first reported a position in AMGN in Q2 2013 and held it in 1 quarter. The position peaked at $1.65M in Q2 2013. 1,061 funds tracked by Wall St. Rank hold AMGN as of Q3 2013.

Alpine Partners USVI reported no remaining Amgen position as of Q3 2013 after selling out during the quarter.
Alpine Partners USVI sold 16,772 Amgen shares in Q3 2013, an estimated $1.65M.
Alpine Partners USVI first reported a position in Amgen in Q2 2013 and held it in 1 quarter.
Alpine Partners USVI's Amgen position peaked at $1.65M in Q2 2013.
1,061 funds tracked by Wall St. Rank held Amgen as of Q3 2013.

Based on Alpine Partners USVI's 13F filing for Q3 2013, filed 14 Nov 2013.